Overview


According to FutureWise analysis, the market for Amniotic Membrane is expected to reach US$ 11.60 billion by 2031 at a CAGR of 15.00%.

An amniotic membrane or amnion is a thin membrane on the internal side of the fetal placenta. It surrounds the embryo and delimits the amniotic cavity, which is loaded with amniotic liquid. The amniotic membrane comprises two layers: an inner layer called the amnion and an outer layer called the chorion. The amniotic membrane has several important functions during pregnancy. It serves as a protective barrier for the developing fetus, providing physical support and preventing infections. It also helps regulate the exchange of gases, waste products, and nutrients between the mother and the fetus. During pregnancy, the amniotic membrane has been found to have therapeutic properties, which contain various growth factors, cytokines, and extracellular matrix components that promote tissue healing, reduce inflammation, and prevent scarring. As a result, the amniotic membrane has been used in various medical applications, including wound healing, ophthalmic surgery, and tissue regeneration.

The amniotic membrane effectively treats various ophthalmic conditions, especially those affecting the ocular surface. Its application in corneal disorders, such as persistent epithelial defects, corneal ulcers, and perforations, has shown promising results. The amniotic membrane is a protective barrier, shielding the affected area while facilitating healing and reducing inflammation. Additionally, it aids in restoring the integrity of the corneal surface. Conjunctival reconstruction is another area where the amniotic membrane has been beneficial, supporting and promoting the regeneration of damaged conjunctival tissue. Its inherent properties, including growth factors and anti-inflammatory components, contribute to its therapeutic effectiveness in ophthalmology.

FutureWise Market Research has published a report that provides an insightful analysis Amniotic Membranes Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, AI in digital pathology market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • FzioMed, Inc.
  • Skye Biologics Inc
  • IOP Ophthalmics
  • Amniox Medical, Inc.
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • Alliqua BioMedical, Inc.
  • Human Regenerative Technologies, LLC
  • Derma Sciences Inc.
  • MiMedx Group, Inc.
  • AlloCure
  • Bellicum Pharmaceuticals
  • Biogen Idec
  • BIOTIME
  • Bone Therapeutics
  • Cell Medica
  • Cesca Therapeutics
  • Fibrocell Science

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Amniotic Membrane Market:

  • In February 2022- TissueTech, a well-known leader in employing cryopreserved human birth tissue products for clinical applications to treat chronic wounds, musculoskeletal conditions, and ocular surface disorders, disclosed its new name and logo. BioTissue, Inc. and Amniox Medical, Inc. will be known under a single entity called BioTissue, Inc.
  • In July 2022- Mearkins Therapeutics launched Dermacyte Matrix. It is an amniotic membrane used to protect and repair damaged tissue.

The growing prevalence of chronic wounds and diabetic foot ulcers drives the demand for amniotic membranes. These membranes are used as a biological dressing to promote injury healing and reduce the risk of infections. With the global population aging, chronic wounds, such as pressure and venous leg ulcers, are also increasing. Elderly individuals are more susceptible to chronic injuries due to reduced skin elasticity, impaired circulation, and underlying health conditions. Amniotic membranes provide a valuable treatment option for these patients by promoting wound healing and improving overall wound outcomes. Additionally, growing healthcare infrastructure and increasing investments in the healthcare sector in emerging economies offer significant opportunities for the amniotic membranes market. These countries are witnessing a rise in chronic diseases and have many patients who may benefit from amniotic membrane-based therapies. Furthermore, the high cost of amniotic membrane treatment is a significant factor that may impede the market growth during the forecast period. The high cost of amniotic membrane treatment could make it unaffordable for a significant portion of the patient population, especially in regions with limited healthcare resources or without inadequate insurance coverage. This may limit the adoption of these therapies and hinder market growth. Moreover, reimbursement challenges in some healthcare systems may impede patient access to these treatments.
 

By Product Type

  • Cryopreservation of Amniotic Membrane
  • Lyophilized Amniotic Membrane
  • Others

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the rising prevalence of ocular diseases like dry eye disease, increasing adoption of advanced medical technologies and techniques, the surge in the number of surgical procedures performed, and heavy presence of leading amniotic membrane providers. The U.S. has one of the most advanced healthcare systems in the world. The industry continuously strives to introduce novel treatments for various diseases. One such development is the adoption of amniotic membranes for testing severe dry disorders.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Amniotic Membranes Market By Product Service, By Component, By Speciality, and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Amniotic Membranes Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amniotic Membranes Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Amniotic Membranes Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Amniotic Membranes Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cryopreservation of Amniotic Membrane
        2. Lyophilized Amniotic Membrane
        3. Others

  • 8.   Amniotic Membranes Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgical Wounds
        2. Ophthalmology
        3. Others

  • 9.   Amniotic Membranes Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Specialized Clinics
        4. Research Centers and Laboratory

  • 10.   North America Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Amniotic Membranes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Fziomed, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Skye Biologics Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. IOP Ophthalmics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Amniox Medical, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Amnio Technology, Llc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Applied Biologics Llc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Alliqua Biomedical, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Human Regenerative Technologies, Llc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Derma Sciences Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Mimedx Group, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Allocure
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Bellicum Pharmaceuticals
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Biogen Idec
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Biotime
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Bone Therapeutics
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Cell Medica
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        17.Cesca Therapeutics
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Fibrocell Science
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Ophthalmology Amniotic Membrane Market

Read More
Partner

Our Clients